Transmitting information to us by e-mail unilaterally does not establish an attorney-client relationship or impose an obligation on either the law firm or even the receiving lawyer to keep the transmitted information confidential. By clicking "OK", you acknowledge that we have no obligation to maintain the confidentiality of any information you submit to us unless we already represent you or unless we have agreed to receive limited confidential material/information from you as a prospective client. Thus, if you are not a client or someone we have agreed to consider as a prospective client, information you submit to us by e-mail may be disclosed to others or used against you. If you would like to discuss becoming a client, please contact one of our attorneys to arrange for a meeting or telephone conference. If you wish to disclose confidential information to a lawyer in the firm before an attorney-client relationship is established, the protections that the law firm will provide to such information from a prospective client should be discussed before such information is submitted. Thank you for your interest in Goodwin Procter.

Goodwin Paris Steps Up in Life Sciences <em>(CF News)</em>

main

04_21 Goodwin Paris Steps Up in Life Sciences

Goodwin has recruited Anne-Charlotte Rivière as a partner in Paris in order to form a venture division dedicated to Life Sciences and Technologies.

Goodwin Paris Steps Up in Life Sciences (CF News)

Related Content

Why the AI Race Hinges on Elite Talent

2026 SEC Exam Priorities for Registered Investment Advisers and Registered Investment Companies

Delaware Court of Chancery Upholds Voting Agreement Amendment That Applied “In the Same Fashion” to All Stockholders

The 15-Minute Founder’s Guide: Pay-to-Play Transactions

America’s AI Action Plan Emphasizes Governance and Risk Management to Promote the Secure and Safe Adoption of AI Tools

Washington Becomes First State to Adopt Filing Requirements for HSR-Reportable Transactions Outside of Healthcare

Delaware Creates More Corporate Clarity and Overhauls Rules Governing Conflicted Transactions

Medtech M&A and VC Signal Positive Momentum Entering 2025

Owlo Raises €1.5 Million

Best Law Firms 2026 Names Goodwin ERISA Litigation Law Firm of the Year and Recognizes 50 Practice Areas

nextProtein Raises €18m in Series B Financing

Chambers UK 2026 Highly Ranks Goodwin UK’s Platform

Speedinvest Invests in the 7 Million Financing of Djust

Goodwin Named an LMG Life Sciences Life Cycle Firm for the Fourteenth Consecutive Year

The Legal 500 UK 2026 Highly Ranks Goodwin’s UK Platform

Goodwin Wins Corporate Firm of the Year, Corporate Attorney of the Year, and Impact Deals of the Year at the LMG Life Sciences Americas Awards

Private Equity

Life Sciences

Technology

Medtech

Venture Capital

Mergers & Acquisitions

Private Equity France

Life Sciences Europe

Technology Europe